A week of Spanish study (5 days of classes) concentrated on your professional specialty. You will have 30 contact classroom hours, as well as opportunities outside the classroom for use of your Spanish. This course may qualify for continuing education units. Information on this is being developed. The course is arranged through Language Link, the U.S. Office for the Spanish Language Institute (800.552.2051, firstname.lastname@example.org), and is sponsored by the AADE California coordinating body.
A university study of 20,000 Chinese adults aged 50 and older says that people who nap four to six days a week have a higher rate of type 2 diabetes than people who either never take a daily snooze or do so less often.
Clinical and basic science researchers from around the world will convene in Hong Kong from January 28 to 30 for the First International Congress on Abdominal Obesity: "Bridging the Gap between Cardiology and Diabetology." The congress, sponsored by the International Chair on Cardiometabolic Risk (ICCR) (http://www.cardiometabolic-risk.org), is the first-ever specialized forum for sharing new insights and evidence about abdominal obesity and its clinical and public health implications.
As an American living abroad, I tried to follow the debate over healthcare reform in the US, but I had to drop it for my own sanity. How could so many of my fellow Americans say that people like me, with chronic diseases we never asked for, should pay more for healthcare because they don't want to participate in the risk pool? How could people like me, who live in fear of losing health insurance, be blind to how badly Americans with type 1 diabetes can get ripped off? I had to remind myself, "It's okay. I don't live there anymore."
"Spanish for Diabetes Educators" is a January, 2010 course arranged through Language Link, the U.S. Office for the Spanish Language Institute and the Multi-Cities chapter of the AADE (McAADE) in California.The course consists of a week of Spanish study (five days of classes) concentrated on your professional specialty. You will have 30 contact classroom hours, as well as opportunities outside the classroom for professional use of your Spanish. This course will qualify for continuing education units.
Professor Peter Schwartz, MD, is a very busy man in the European diabetes community. He's a professor of medicine, a scientist, and a medical doctor in the Division of Prevention and Care of Diabetes, Department of Medicine, University of Dresden. It's a mystery how he finds enough hours in the day to do what he does. Diabetes Health recently interviewed him via email since he lives and works in Dresden, Germany.
MONTREAL, Canada, 19 October 2009 - The International Diabetes Federation's 20th World Diabetes Congress opened today at the Palais de Congress in Montreal, Quebec. The five-day congress brings thousands of international delegates to the Canadian city to discuss burning issues in diabetes care and examine local, national and regional solutions to a growing global problem.
South African researchers have found that in areas where tuberculosis is endemic, nearly one in three children and adolescents with type 1 diabetes tests positive when given a skin test for the disease. Although the positive test results do not mean that these young people will inevitably develop active TB, they do run a very high risk of doing so.
The need to investigate and determine normoglycemia in Mexican children under the age of six begins with a lack of relevant published data. Another motive for reviewing the currently recommended glycemic goals for children and adolescents with type 1 stems from the well-known observation that children and adolescents who do not have type 1 do not develop microvascular diabetic complications. Today, thanks to insulin analogs and basal/bolus therapy regimens, children with type 1 have the option of achieving true euglycemia and of potentially benefiting from its advantages.
Can you imagine a hospital where the floors are carpeted, so you feel soothed and protected? Where the doors open silently so as not to jar your nerves? Where vending machines are filled with fresh fruits, and the healthier the meal in the cafeteria, the less it costs? How about elevator doors covered in exotic floral motifs, or a diabetes center where you never wait more than ten minutes to be seen?
Asia, which covers an area almost twice the size of North America and is home to three billion people-half of humanity-is often seen as a homogenous entity in the minds of many Westerners, even scientists. But a land that stretches 6,000 miles from east to west is anything but homogenous. The Israelis and Arabs in western Asia, for example, are far different ethnically from the Hmong mountain people in Southeast Asia, the Ainu in northern Japan, or the Filipinos in the southwestern Pacific.
Now you can read Diabetes Health in over 30 languages! Look for the Google Translate button in the left-hand navigational column on any of our pages. You can translate the text on the page by clicking the language of your choice in the drop-down menu.
Today is not the first World Diabetes Day. This day was designated World Diabetes Day in 1991 by the International Diabetes Federation (IDF) and the World Health Organization (WHO). It has been celebrated each year on November 14 since then.
The diagnosis of type 1 diabetes peaks at 13 to 14 years of age, but at any age it immediately requires children and adolescents to learn many complex facets of glycemic self-management. Dr. Elliot Joslin's belief of 85 years ago, that education is not just part of the treatment of diabetes, but rather the treatment itself, still holds true.
Every year since 1991,the International Diabetes Federation (IDF) and the World Health Organization (WHO) have designated November 14th as World Diabetes Day. In 2007, it also became an official United Nations World Day.
The members of the AADE are an impassioned group who genuinely want to make a difference in their patients' lives. It was an ideal place for me to be, especially because I had a concern of my own: Why am I getting red dots every time I inject? Every educator I asked went right to work examining the problem and investigating my behavior, truly wanting to help. Unfortunately, they are dwindling in number each year, while patients are increasing in number, making their work ever more demanding.
People with diabetes are at increased risk of developing tuberculosis (TB), according to a review of published studies. As a result, the increasing prevalence of diabetes may threaten global efforts to control TB, suggest researchers at Harvard School of Public Health in Boston in the latest issue of the journal PLoS (Public Library of Science) Medicine.
If your summer travels take you south of the border into Mexico, pharmacists say you should avoid the temptation of saving a few dollars by purchasing your medications at farmacias, which sell versions of American prescription drugs made in Mexico.
A new Spanish language consumer guide to type 2 diabetes, called “Pastillas para la diabetes tipo 2,” has been released by the Agency for Healthcare Research and Quality (AHRQ). The guide provides information on how to control type 2 and includes comparisons of oral medications. AHRQ data show that nearly one in eight Hispanics takes a prescription drug for diabetes.
Have you heard the story of the little boy who was on the beach after a storm? Thousands of starfish had washed ashore, and he picked up one after another and threw them back into the sea. A man watched him work and after some time said to the boy, “Look at all these starfish. You’re never going to be able to save them all. Do you think all your work will make a difference?” The boy thought for a minute as he looked up and down the beach. “I don’t know,” he said as he picked up another starfish and flung it into the brine, “but it sure will make a difference to this one!”
Every pilot’s nightmare is the thought of losing his medical certification and being stopped from flying. That happened to me in May of 1986, when I was diagnosed with type 1. In accordance with the International Civil Aviation Organization (ICAO) Standards and Recommended Practices, Canada, along with every other country in the world, would not allow insulin-dependent pilots to hold any type of pilot’s license. My short eight-year career with Air Canada came to an abrupt end, and I was told in no uncertain terms that I would never be allowed to fly an aircraft again.
The FDA is currently reviewing a continuous glucose monitoring system from Abbott, the "FreeStyle Navigator." The CGM device, if approved, will join the CGM systems currently offered by Medtronic and Dexcom.
Adults with type 2 diabetes who follow individually tailored self-management programs are better able to lower their blood pressure and weight and maintain them over time than adult diabetes patients who don't, say Dutch researchers.
El Paso, Texas, October 31, 2007 - Diabetes has become the leading cause of death in Mexico and the third-leading cause of death among those living along the U.S. side of the border, according to a new study presented today by the Pan American Health Organization (PAHO).
Frost & Sullivan, whose mission is to research and analyze new market opportunities for corporate growth, has some happy news about the diabetes epidemic: It's creating a huge demand for glucose meters and strips in Asia.
Fat deep inside your abdomen, called visceral fat, collects and clusters around your vital organs. From there, it sends out proteins and hormones that are associated with type 2 diabetes, hypertension, and heart disease.
An ongoing study of 1,000 construction workers in Ireland has revealed a problem: Of the 450 who have been tested to date, nearly half are overweight, ten percent are pre-diabetic, and a number have been discovered to have type 2 diabetes.
New York, NY - March 13, 2007 - Former President Bill Clinton joined global diabetes leaders today in New York City to discuss ways to break the curve of the diabetes pandemic at a forum hosted by Novo Nordisk and supported by the International Diabetes Federation (IDF).
PRINCETON, N.J. - January 25, 2007 - Former President Bill Clinton will be the keynote speaker at the Global Changing Diabetes Leadership Forum, taking place on March 13, 2007 in New York City hosted by Novo Nordisk and supported by the International Diabetes Federation.
Italian researchers say that kidney disease is a “significant predictor” of death, and that people who have kidney problems at the time of their diabetes diagnosis should be treated aggressively from the onset.
Researchers in Italy say that ype 1s who undergo a successful pancreas transplant alone, without having a kidney transplant as well, have improved kidney function as well as restored normal blood glucose levels without the need for insulin therapy.
Metformin activates the enzyme AMPK (AMP-activated protein kinase), which promotes muscles to take up glucose from the blood. It was recently discovered that the upstream regulator of AMPK is a protein kinase called LKB1, known to be a tumor suppressor.
A vaccine for type 1s will be tested on 18 human volunteers with type 1 this summer in the United Kingdom. Researchers at the University of Bristol in southwest England and King’s College in London say that the vaccine could be on the market in 10 years’ time.
A recent Swedish study shows that type 1 status affects the risk for stomach, cervical, and endometrial cancers. However, the risk of breast, colon, rectal, pancreatic, and kidney cancers is not affected by type 1 status.
It seems too good to be true, but researchers from Queen Mary’s School of Medicine and Dentistry in London are advancing a new therapy to reduce the cardiovascular risk factors of high blood cholesterol, blood pressure, blood homocysteine levels, and platelet clumping—all in one pill.
Roche, best known for its Accu-Chek family of blood-glucose monitors, made an offer in February 2003 to buy Disetronic's insulin pump division. A decision on the purchase should be finalized in May or June if Disetronic's shareholders accept Roche's tender offer of two nonvoting Roche equity securities and a price of 670 Swiss francs (about $490 U.S. dollars) per share.
German researchers propose that a synthetic derivative of thiamine, or vitamin B1, may be useful in preventing blindness, limb loss, kidney failure and other complications of diabetes that are caused by high blood-glucose levels.
Children born in Denmark after 1985 are at increased risk of developing type 1 diabetes, say researchers involved in the Danish Study Group of Diabetes in Childhood, who evaluated trends in age-specific incidence rates between 1970 and 2000.
Can drinking water contribute to your risk of getting type 1 diabetes? Maybe, say researchers who analyzed the acidity, color and mineral content of tap water from the homes of 64 people with type 1 diabetes and 250 randomly selected control subjects.
In a report published in the March 2002 issue of the Archives of Disease in Childhood, England records its first cases of type 2 diabetes among Caucasian adolescents. (Cases of type 2 diabetes among adolescents of other racial groups have already been reported.)
The incidence of type 1 diabetes among the children of northeastern Poland doubled in just four years, according to a study published in the October 2001 issue of Diabetologia. The increase occurred primarily in rural areas, with the highest incidence rates recorded during the winter.
Researchers in Ireland suggest that a country's wealth could be a factor contributing to the incidence of type 1 diabetes. Christopher C. Patterson, senior lecturer at Queen's University in Belfast, studied the incidence of type 1 diabetes across Europe and how it related to each nation's economy. Results of the study were published in Supplement 3 of the October 2001 issue of Diabetologia.
Nearly one-quarter of research subjects with type 1 diabetes who had diabetic kidney disease showed signs of remission of their kidney disorder after beginning treatment with angiotensin-converter enzyme (ACE) inhibitors, say researchers at the Steno Diabetes Center in Gentofte, Denmark.
Taking estrogen decreases the risk of heart disease slightly in post-menopausal women with diabetes, say researchers in New Zealand. Patrick J. Manning, MBChB, and colleagues, from the departments of medicine at the University of Otago in Dunedin, New Zealand, demonstrated positive changes in the blood cholesterol and blood-clotting factors of middle-aged women with diabetes when they were given hormone replacement therapy. Findings were published in the July 23 issue of the Archives of Internal Medicine.
Researchers at three centers in the United Kingdom have been successful in demonstrating that using an insulin pump helps to control blood sugar and A1c levels, and can assist in preventing serious diabetes complications in a variety of patients—from long-term type 1s with erratic control to children and pregnant women.
For type 1s who fast during Ramadan, it was discovered that blood-sugar control—measured by after-meal readings—was improved and hypoglycemia significantly reduced when using insulin lispro compared with Regular human insulin.
Type 1 diabetes among children in Baden-Wuerttemberg, in Southwest Germany, has been rising at an average annual rate of 3.6 percent and researchers calculate that the rate will double within 20 years.
Japanese researchers are saying it is important for people with diabetes with normal blood-pressure levels to be on a salt-restricted diet long before the occurrence of any type of high blood pressure. In an August 24, 2000, interview with Reuters Health, M. Imanishi, MD, of Osaka City General Hospital, said, "Before hypertension, salt-sensitivity appears, especially in diabetic patients, because of the renal damage caused by the diabetes."
The following is a summary of Classen Immunotherapies' efforts to prove the correlation between infant vaccination and the development of type 1 diabetes, as reported in professional scientific journals.
On February 24, the U.S. Food and Drug Administration (FDA) warned people with diabetes not to use five brands of Chinese herbal products. The FDA says that the herbs illegally contain the prescription diabetes drugs glyburide and phenformin which can cause dangerous drops in blood sugar.
Dr. Sharad Pendsey is a physician based in Nagpur, India. Pendsey recalls the story of a girl named Sudha who came to him when she was eight-years old. Sudha had just been diagnosed with type 1 diabetes. When she was discharged from the hospital, Pendsey explained to Sudha's impoverished parents that she would have to take insulin to stay alive. Pendsey recalls Sudha's parents asking, "Doctor, if I understand you correctly, Sudha has to take insulin every day for the rest of her life?" Pendsey nodded yes, and said that Sudha would die if she didn't. The parents understood the predicament, but could not afford the cost of her insulin. One month later, Pendsey learned that Sudha had died.
In spite of a diet rich in saturated fat, the French have a much lower rate of cardiovascular disease than Americans. Researchers attribute this to the consumption of red wine, which has the power to bolster antioxidants in blood.
Researchers have long suspected a link between enterovirus infections and the development of type 1 diabetes. In a report published in the December 1999 issue of Diabetes Care, a team of Finnish and Lithuanian scientists has uncovered more evidence to support this.
Researchers at the University of Ancona in Italy discovered a statistically significant difference in the incidence of childhood type 1 diabetes among people living in Italy. The more populated urban areas had almost double the type 1 rate of the rural areas. The researchers hypothesize that in the urban areas, there is probably genetic mingling because of continuous migration, whereas the genetic background of the original population is conserved better in rural areas.
The incidence of new type 1 cases in American children age 14 and younger is approximately 15 per 100,000 children. In Finland, however, the incidence of type 1 diabetes in children age 14 and younger is around 45 per 100,000 people, making it the highest in the world.
Beef-pork insulin will soon disappear in the United States, leaving thousands of people with diabetes without the insulin they feel is essential to their lives. Ever since insulin manufacturers Eli Lilly and Novo Nordisk announced that they would no longer sell beef-pork insulin, American activists have been fighting to import it from the United Kingdom and Brazil, where it is still made and widely available. The activists work on behalf of those who say that human insulin causes side effects in them, the most frequently reported being that they no longer get any physical warning when their blood sugars drop.
Jean Chediac has type 2 diabetes and had not taken his medication for a week, running his BGs up to double their normal level. He finally went to his health care provider, who gave him his medicine. Within a day, his BGs were back to normal.
For many years, sulfated beef insulin has been produced for insulin users. By 1993 there were 26 people taking sulfated beef insulin in Canada. By 1996 only 15 people were still using sulfated beef insulin.
MiniMed Inc., with its implantable insulin pump, and Medical Research Group LLC (MRG), with its implantable glucose sensor, recently reached an agreement in an attempt to ease an implantable insulin system into the U.S. market.
In the June issue of Diabetologia: the Journal of the European Association for the Study of Diabetes, researchers argued whether sulphonylurea drugs (such as Micronase, Glucotrol, DiaBeta, Glynase, Amaryl and Diabinese) pose an increased cardiovascular risk for individuals with type 2 diabetes and heart disease. (Sulphonylurea drugs are prescribed to help stimulate the beta cells of individuals with type 2 diabetes; it may also increase the sensitivity of muscle tissue to the hormone.)
The International Olympic Committee (IOC) recently added insulin to its list of banned substances for all nondiabetic athletes. According to the IOC, insulin, while used by people with diabetes to control blood sugar levels, can be used by nondiabetic athletes to gain muscle mass. Its misuse can have an adverse affect on health, possibly leading to death.
Results of a study by Naomi D. Neufeld, MD, et al. describe the signals that the beginning of type 2 diabetes is present in some Hispanic populations. As reported in January's Diabetes Care, there is a genetic predisposition, that when combined with obesity, can result in type 2 diabetes in Mexican-American children.
When human insulin first appeared on the market it was thought to be a "special" insulin and the beef/pork insulin that I had taken for years was termed "standard" insulin. A lot has changed since those days. What was once thought to be the standard is now in danger of being pulled from the market.
The British Diabetic Association's (BDA's) insulin campaign is committed to securing choice for people with diabetes for the kind of insulin that they use. The BDA is therefore committed to securing long-term availability of animal and human insulins, and provision of animal insulins in pen cartridges.
The American Diabetes Association recognizes patients' concerns with the discontinuation of mixed beef/pork insulin production in the United States. Patients need and deserve adequate education and assistance as they switch to either pure pork or human insulin. We strongly urge insulin-producing companies to recognize these concerns as well, and take steps necessary to give providers the tools to help their patients make this transition.
(Our) survey results indicate that for some people, changing insulins has a negative impact on their health, well-being and quality of life. People need more information as to the reasons for changing their insulin and they need to have the choice. They need the support of their physicians and their diabetes health care teams during this time of change-over. The (Canadian) National Advocacy Committee is committed to advocating for the continuation of beef/pork insulins for those whose health, well-being or quality of life will be affected by the change.
I recently visited the Golden Triangle of Central Europe (the cities of Vienna, Budapest and Prague) with seven friends. In the golden city of Prague I had the immense pleasure of meeting much of the staff at the Institute for Clinical and Experimental Medicine's Diabetes Clinic, the Klinika Diabetologie. Everyone I met in Prague exuded such hospitality and such a optimistic outlook for these changing times in this historical city. The staff at the Klinika was no exception.
DIABETES HEALTH received the following letter from Advisory Board Member Matthew Kiln, MB, BS, DRCOG, FRSH, from the Paxton Green Health Center in London. The UK Diabetes Adviser wrote in response to "Hypoglycemia: What Every Person Should Know" in the July issue.
How and why type I diabetes develops continues to puzzle doctors and researchers the world over. A recent report in the March issue of Diabetes Care illustrates one of its most interesting and unexplained characteristics. The disease, while not communicable, has a tendency to break out in "epidemics."
A new indicator of atherosclerosis for people with type 2 diabetes has been discovered. French scientists have found that the levels of a blood protein called A-IV is a very strong indicator of arterial problems in the heart, limbs and brain.
A recent study suggests type I diabetes may be linked to time and place of birth. This is congruent with time and place clustering for a viral epidemic, and adds more weight to the growing theory that some cases of type I diabetes are caused by viral infection.
The European Parliament continues to debate whether diabetic foods should be regulated by the government, according to recent Reuters reports. All countries in the European Union (EU) oppose such regulation, except Germany.
Vitamin E may decrease the risk of developing some of the most common complications of diabetes, according to a study done at Joslin Diabetes Center, Brigham and Women's Hospital in Boston, and Kyushu University in Japan.
A study comparing the hypoglycemic effects of evening and morning injections in patients with non-insulin dependent diabetes (NIDDM) was conducted by the University of Helsinki, Finland (Diabetes Care, August 1994). Researchers determined that the hypoglycemic effects of the two treatments were similar. For patients using a combination of Regular and NPH therapy, insulin can be administered equally well during the night and during the day. The researchers were trying to determine when glucose production is most abnormal. They had hypothesized that nocturnal insulin injections might be more effective, because glucose production in the body is maximal during the night.
A recent report from the University of Kuopio in Finland has found that fructose may be an acceptable alternative to sugar in the diet of people with diabetes who are liable to high after meal glucose concentrations (American Journal of Clinical Nutrition, March 1994). In patients with mild non-insulin-dependent diabetes mellitus, fructose may contribute lower after meal glucose and insulin responses than most other carbohydrate sources.
Researchers at the University of Sydney in New South Wales, Australia, are calling for a reassessment of the value of the glycemic index in the treatment of diabetes (American Journal of Clinical Nutrition, March 1994). They cite 11 medium to long-term studies that have specifically used the glycemic index (GI) approach to determine clinical gains in diabetes or lipid management. All but one study produced positive findings.
In Tonga, a small island kingdom in the South Pacific with a population of about 100,000 people, girth is a sign of success. Western-style medical care tends to be utilized only for illnesses related to the West, and hospitals are viewed as places for people with life threatening illnesses; as many as 70% of the patients go there to die. These insights gained by Ruth Breitenbach, a nurse and diabetes educator at Redwood City Kaiser in California, and her colleague Donna Wright, MA, RN, have helped them pioneer a successful, culturally sensitive diabetes education program aimed at the Tongan population in Redwood City. Tongan-Americans comprise a large percentage of the patients treated for diabetes there.
A survey recording the rate of type 1 diabetes among children under 15 years of age has found that Macedonia has the lowest incidence of IDDM in Europe, with only 112 cases reported in 6 years. The overall number of cases was 2.45 per 100,000 people per year (the rate in the United States is between 4 and 15 cases per 100,000 people per year, depending on location and ethnicity).
A team of French researchers report the success of an experimental study involving the implantation of a programmable insulin pump in 214 patients with insulin-dependent diabetes. The pumps used in the study were the MiniMed MIP 2001, the Infusaid M1000, and the Promedos 3. The pumps were implanted into the abdominal wall, with catheters inserted into the peritoneum (the membrane sac lining the abdominal cavity).
A study from Turin, Italy, has found a higher incidence of type 1 diabetes in males than in females in the age group of 15-29 years old. The report of the study, published in Diabetes Care, January 1993, recalls previous studies from Sweden and Spain in similar age groups that found males to be a greater risk of developing insulin-dependent diabetes mellitus.
A study from France has concluded that implantable insulin pumps have proven to be reasonably safe and effective on a large scale, although time-limited, basis. The study was conducted by researchers from the EVADIAC Group in France.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.